TAMPA, FL and SEOUL, SOUTH KOREA--(Marketwire - April 01, 2008) - Stem Cell Therapy International, Inc. (OTCBB: SCII) and Histostem Corp. (Korea Histostem).
Stem Cell Therapy International (SCII) announced today it has appointed Dr. David L. Stark as president in anticipation of the upcoming merger with Histostem of Korea, one of the world's leading umbilical cord stem cell blood banks and research companies in the field of stem cell treatments for various illnesses. After the closing of the merger between SCII and Histostem the name of the combined entities will be changed to AmStem International Corporation and Dr. Stark will continue in his capacity as president and member of the board of directors. Dr. Hoon Han of Histostem will be chairman of the board and CEO of AmStem International.
